同型半胱氨酸与冠状动脉疾病的关联。
The association of homocysteine and coronary artery disease.
作者信息
Gauthier Gregory M, Keevil Jon G, McBride Patrick E
机构信息
Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, Wisconsin 53792, USA.
出版信息
Clin Cardiol. 2003 Dec;26(12):563-8. doi: 10.1002/clc.4960261204.
Abstract
Hyperhomocysteinemia has been associated with increased risk of atherosclerosis and myocardial infarction by a number of prospective case-control studies. A variety of genetic mutations, nutritional deficiencies, disease states, and drugs can elevate homocysteine concentrations. Treatment with folic acid with or without B-complex vitamins effectively lowers homocysteine levels. Whether therapy corresponds with decreased risk of coronary events is unknown, but may be promising. This article reviews the biochemistry of homocysteine metabolism, pathogeneisis, and etiology of hyperhomocysteinemia, along with its association with coronary artery disease, screening, and treatment.
摘要
多项前瞻性病例对照研究表明，高同型半胱氨酸血症与动脉粥样硬化和心肌梗死风险增加有关。多种基因突变、营养缺乏、疾病状态和药物均可使同型半胱氨酸浓度升高。使用叶酸加或不加复合维生素B进行治疗可有效降低同型半胱氨酸水平。治疗是否与降低冠状动脉事件风险相关尚不清楚，但可能很有前景。本文综述了同型半胱氨酸代谢的生物化学、高同型半胱氨酸血症的发病机制和病因，以及它与冠状动脉疾病、筛查和治疗的关系。
相似文献
1
The association of homocysteine and coronary artery disease.同型半胱氨酸与冠状动脉疾病的关联。
Clin Cardiol. 2003 Dec;26(12):563-8. doi: 10.1002/clc.4960261204.
2
Homocysteine: a new cardiac risk factor?同型半胱氨酸：一种新的心脏危险因素？
Clin Cardiol. 2001 Jan;24(1):80-4. doi: 10.1002/clc.4960240113.
3
Homocysteine, B vitamins, and coronary artery disease.
Med Clin North Am. 2000 Jan;84(1):215-37, x. doi: 10.1016/s0025-7125(05)70215-7.
4
[Homocysteine and coronary artery disease].[同型半胱氨酸与冠状动脉疾病]
Duodecim. 2003;119(12):1131-5.
5
Homocysteine and coronary risk.同型半胱氨酸与冠心病风险。
Curr Cardiol Rep. 1999 Jul;1(2):91-8. doi: 10.1007/s11886-999-0065-1.
6
[Homocysteine. The cardiovascular risk factor of the next millennium?].[同型半胱氨酸。下个千年的心血管危险因素？]
An Med Interna. 2001 Apr;18(4):211-7.
7
Homocysteine, vitamin B12 and folate levels in premature coronary artery disease.早发性冠状动脉疾病中的同型半胱氨酸、维生素B12和叶酸水平
BMC Cardiovasc Disord. 2006 Sep 26;6:38. doi: 10.1186/1471-2261-6-38.
8
[Hyperhomocysteinemia in pediatric age and nutritional aspects of folates: an early cardiovascular risk factor].[儿童期高同型半胱氨酸血症与叶酸的营养方面：一种早期心血管危险因素]
Monaldi Arch Chest Dis. 2006 Dec;66(4):275-85. doi: 10.4081/monaldi.2006.519.
9
Homocysteine and coronary heart disease: a review of the current evidence.
Semin Interv Cardiol. 1999 Sep;4(3):121-8. doi: 10.1053/siic.1999.0084.
10
The current status of homocysteine as a risk factor for cardiovascular disease: a mini review.同型半胱氨酸作为心血管疾病风险因素的现状：一篇综述短文
Expert Rev Cardiovasc Ther. 2018 Aug;16(8):559-565. doi: 10.1080/14779072.2018.1497974. Epub 2018 Jul 17.
引用本文的文献
1
Atherogenic Effect of Homocysteine, a Biomarker of Inflammation and Its Treatment.同型半胱氨酸（一种炎症生物标志物）的致动脉粥样硬化作用及其治疗
Int J Angiol. 2024 Jul 8;33(4):262-270. doi: 10.1055/s-0044-1788280. eCollection 2024 Dec.
2
Sortilin and Homocysteine as Potential Biomarkers for Coronary Artery Diseases.Sortilin和同型半胱氨酸作为冠状动脉疾病的潜在生物标志物
Int J Gen Med. 2021 Sep 27;14:6167-6176. doi: 10.2147/IJGM.S324889. eCollection 2021.
3
B12 and Folate Concentrations in Opium Addicts Compared to Healthy Subjects: A Case Control Study from Kerman Coronary Artery Disease Risk Study.与健康受试者相比，鸦片成瘾者体内维生素B12和叶酸浓度：来自克尔曼冠状动脉疾病风险研究的病例对照研究
Addict Health. 2018 Jul;10(3):198-204. doi: 10.22122/ahj.v10i3.547.
4
Genetic interactions between MTHFR (C677T), methionine synthase (A2756G, C2758G) variants with vitamin B12 and folic acid determine susceptibility to premature coronary artery disease in Indian population.亚甲基四氢叶酸还原酶（MTHFR，C677T）、蛋氨酸合成酶（A2756G、C2758G）基因变异与维生素B12和叶酸之间的基因相互作用决定了印度人群患早发性冠状动脉疾病的易感性。
J Cardiovasc Dis Res. 2011 Jul;2(3):156-63. doi: 10.4103/0975-3583.85262.
本文引用的文献
1
Secondary prevention with folic acid: effects on clinical outcomes.叶酸二级预防：对临床结局的影响。
J Am Coll Cardiol. 2003 Jun 18;41(12):2105-13. doi: 10.1016/s0735-1097(03)00485-6.
2
Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial.叶酸、维生素B12和维生素B6降低同型半胱氨酸治疗对经皮冠状动脉介入治疗后临床结局的影响：瑞士心脏研究：一项随机对照试验
JAMA. 2002 Aug 28;288(8):973-9. doi: 10.1001/jama.288.8.973.
3
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.血浆同型半胱氨酸水平降低后冠状动脉再狭窄率降低。
N Engl J Med. 2001 Nov 29;345(22):1593-600. doi: 10.1056/NEJMoa011364.
4
Hyperhomocystinemia: a risk factor or a consequence of coronary heart disease?
Arch Intern Med. 2001 Jul 9;161(13):1589-94. doi: 10.1001/archinte.161.13.1589.
5
Homocysteine and major coronary events: a prospective population study amongst women.
J Intern Med. 2001 May;249(5):461-5. doi: 10.1046/j.1365-2796.2001.00830.x.
6
Acute and convalescent changes in plasma homocysteine concentrations in acute coronary syndromes.急性冠状动脉综合征患者血浆同型半胱氨酸浓度的急性及恢复期变化
Heart. 2001 Apr;85(4):380-4. doi: 10.1136/heart.85.4.380.
7
Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease.
Circulation. 2000 Sep 12;102(11):1227-32. doi: 10.1161/01.cir.102.11.1227.
8
Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes.
Circulation. 2000 Aug 8;102(6):605-10. doi: 10.1161/01.cir.102.6.605.
9
Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes.血清同型半胱氨酸浓度作为急性冠脉综合征患者生存情况的一项指标。
Arch Intern Med. 2000 Jun 26;160(12):1834-40. doi: 10.1001/archinte.160.12.1834.
10
Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acid.接受环孢素或他克莫司治疗的肾移植患者的血浆同型半胱氨酸水平：叶酸治疗的效果
Clin Transplant. 2000 Apr;14(2):110-4. doi: 10.1034/j.1399-0012.2000.140202.x.
Zotero 插件